Aevi Genomic Medicine Announces 2017 Investor Day
Aevi Genomic Medicine to Present at the Leerink Partners 6th Annual Global Healthcare Conference
Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome
Leaders in genetic science and commercial drug development
Discover the future of novel genetic therapies currently being researched by Aevi Genomic Medicine.
Presentations, information, and news